Osteoporosis management in patient with renal function impairment
Autor(a) principal: | |
---|---|
Data de Publicação: | 2014 |
Outros Autores: | , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Arquivos Brasileiros de Endocrinologia & Metabologia (Online) |
Texto Completo: | http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0004-27302014000500530 |
Resumo: | Aging is associated with decreases in bone quality and in glomerular filtration. Consequently, osteoporosis and chronic kidney disease (CKD) are common comorbid conditions in the elderly, and often coexist. Biochemical abnormalities in the homeostasis of calcium and phosphorus begin early in CKD, leading to an increase in fracture risk and cardiovascular complications since early stages of the disease. The ability of DXA (dual energy X-ray absorptiometry) to diagnose osteoporosis and to predict fractures in this population remains unclear. The management of the disease is also controversial: calcium and vitamin D, although recommended, must be prescribed with caution, considering vascular calcification risk and the development of adynamic bone disease. Furthermore, safety and effectiveness of osteoporosis drugs are not established in patients with CKD. Thus, risks and benefits of antiosteoporosis treatment must be considered individually. |
id |
SBEM-2_bfbbda90bdde30c68ea5de9aa9884970 |
---|---|
oai_identifier_str |
oai:scielo:S0004-27302014000500530 |
network_acronym_str |
SBEM-2 |
network_name_str |
Arquivos Brasileiros de Endocrinologia & Metabologia (Online) |
repository_id_str |
|
spelling |
Osteoporosis management in patient with renal function impairmentBone qualityCKD-MBDDXAfracturesosteoporosisAging is associated with decreases in bone quality and in glomerular filtration. Consequently, osteoporosis and chronic kidney disease (CKD) are common comorbid conditions in the elderly, and often coexist. Biochemical abnormalities in the homeostasis of calcium and phosphorus begin early in CKD, leading to an increase in fracture risk and cardiovascular complications since early stages of the disease. The ability of DXA (dual energy X-ray absorptiometry) to diagnose osteoporosis and to predict fractures in this population remains unclear. The management of the disease is also controversial: calcium and vitamin D, although recommended, must be prescribed with caution, considering vascular calcification risk and the development of adynamic bone disease. Furthermore, safety and effectiveness of osteoporosis drugs are not established in patients with CKD. Thus, risks and benefits of antiosteoporosis treatment must be considered individually.Sociedade Brasileira de Endocrinologia e Metabologia2014-07-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0004-27302014000500530Arquivos Brasileiros de Endocrinologia & Metabologia v.58 n.5 2014reponame:Arquivos Brasileiros de Endocrinologia & Metabologia (Online)instname:Sociedade Brasileira de Endocrinologia e Metabologia (SBEM)instacron:SBEM10.1590/0004-2730000003360info:eu-repo/semantics/openAccessLima,Guilherme Alcantara CunhaParanhos Neto,Francisco de PaulaPereira,Giselly Rosa ModestoGomes,Carlos PerezFarias,Maria Lucia Fleiusseng2014-08-19T00:00:00Zoai:scielo:S0004-27302014000500530Revistahttps://www.aem-sbem.com/ONGhttps://old.scielo.br/oai/scielo-oai.php||abem-editoria@endocrino.org.br1677-94870004-2730opendoar:2014-08-19T00:00Arquivos Brasileiros de Endocrinologia & Metabologia (Online) - Sociedade Brasileira de Endocrinologia e Metabologia (SBEM)false |
dc.title.none.fl_str_mv |
Osteoporosis management in patient with renal function impairment |
title |
Osteoporosis management in patient with renal function impairment |
spellingShingle |
Osteoporosis management in patient with renal function impairment Lima,Guilherme Alcantara Cunha Bone quality CKD-MBD DXA fractures osteoporosis |
title_short |
Osteoporosis management in patient with renal function impairment |
title_full |
Osteoporosis management in patient with renal function impairment |
title_fullStr |
Osteoporosis management in patient with renal function impairment |
title_full_unstemmed |
Osteoporosis management in patient with renal function impairment |
title_sort |
Osteoporosis management in patient with renal function impairment |
author |
Lima,Guilherme Alcantara Cunha |
author_facet |
Lima,Guilherme Alcantara Cunha Paranhos Neto,Francisco de Paula Pereira,Giselly Rosa Modesto Gomes,Carlos Perez Farias,Maria Lucia Fleiuss |
author_role |
author |
author2 |
Paranhos Neto,Francisco de Paula Pereira,Giselly Rosa Modesto Gomes,Carlos Perez Farias,Maria Lucia Fleiuss |
author2_role |
author author author author |
dc.contributor.author.fl_str_mv |
Lima,Guilherme Alcantara Cunha Paranhos Neto,Francisco de Paula Pereira,Giselly Rosa Modesto Gomes,Carlos Perez Farias,Maria Lucia Fleiuss |
dc.subject.por.fl_str_mv |
Bone quality CKD-MBD DXA fractures osteoporosis |
topic |
Bone quality CKD-MBD DXA fractures osteoporosis |
description |
Aging is associated with decreases in bone quality and in glomerular filtration. Consequently, osteoporosis and chronic kidney disease (CKD) are common comorbid conditions in the elderly, and often coexist. Biochemical abnormalities in the homeostasis of calcium and phosphorus begin early in CKD, leading to an increase in fracture risk and cardiovascular complications since early stages of the disease. The ability of DXA (dual energy X-ray absorptiometry) to diagnose osteoporosis and to predict fractures in this population remains unclear. The management of the disease is also controversial: calcium and vitamin D, although recommended, must be prescribed with caution, considering vascular calcification risk and the development of adynamic bone disease. Furthermore, safety and effectiveness of osteoporosis drugs are not established in patients with CKD. Thus, risks and benefits of antiosteoporosis treatment must be considered individually. |
publishDate |
2014 |
dc.date.none.fl_str_mv |
2014-07-01 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0004-27302014000500530 |
url |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0004-27302014000500530 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
10.1590/0004-2730000003360 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
text/html |
dc.publisher.none.fl_str_mv |
Sociedade Brasileira de Endocrinologia e Metabologia |
publisher.none.fl_str_mv |
Sociedade Brasileira de Endocrinologia e Metabologia |
dc.source.none.fl_str_mv |
Arquivos Brasileiros de Endocrinologia & Metabologia v.58 n.5 2014 reponame:Arquivos Brasileiros de Endocrinologia & Metabologia (Online) instname:Sociedade Brasileira de Endocrinologia e Metabologia (SBEM) instacron:SBEM |
instname_str |
Sociedade Brasileira de Endocrinologia e Metabologia (SBEM) |
instacron_str |
SBEM |
institution |
SBEM |
reponame_str |
Arquivos Brasileiros de Endocrinologia & Metabologia (Online) |
collection |
Arquivos Brasileiros de Endocrinologia & Metabologia (Online) |
repository.name.fl_str_mv |
Arquivos Brasileiros de Endocrinologia & Metabologia (Online) - Sociedade Brasileira de Endocrinologia e Metabologia (SBEM) |
repository.mail.fl_str_mv |
||abem-editoria@endocrino.org.br |
_version_ |
1754734812722102272 |